Skip to main content

6 Result(s)

within O Della Casa Alberighi Remove this filter

and

  1. Article

    Open Access

    Development of the autoinflammatory disease damage index (ADDI)

    K Annink, N ter Haar, M Gattorno, H Lachmann… in Pediatric Rheumatology (2015)

    Download PDF (225 KB) View Article

  2. Article

    Open Access

    Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)

    L Trieste, O Della Casa Alberighi, G Turchetti, F Pierotti… in Pediatric Rheumatology (2015)

    Download PDF (266 KB) View Article

  3. Article

    Open Access

    The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)

    O Della Casa Alberighi, L Trieste, L Accame, V Lorenzoni… in Pediatric Rheumatology (2015)

    Download PDF (268 KB) View Article

  4. Article

    Open Access

    PW02-027 - CAPS and cost-effectiveness analysis project

    O Della Casa Alberighi, L Accame, J Frenkel, M Gattorno… in Pediatric Rheumatology (2013)

    Download PDF (269 KB) View Article

  5. No Access

    Chapter

    Combination treatment in autoimmune diseases: systemic lupus erythematosus

    Systemic lupus erythematosus (SLE) is a potentially life-threatening chronic inflammatory disorder characterised by the overproduction of autoantibodies and other immunological abnormalities, which may affect ...

    G. Moroni, O. Della Casa Alberighi… in Combination Treatment in Autoimmune Diseas… (2002)

  6. No Access

    Article

    Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus

    The positive results obtained with cyclosporine-A both in an experimental model and in selected patients with advanced systemic lupus erythematosus support the hypothesis that the drug could be used as a stero...

    F. Dammacco, O. Della Casa Alberighi… in International Journal of Clinical and Labo… (2000)